Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-04-06

Clinical Trial Update: Remifentanil-dexmedetomidine Anesthesia With a Caudal for Elective Surgery. (Remi-dex) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial on remifentanil-dexmedetomidine anesthesia with a caudal for elective surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remifentanil-dexmedetomidine

Snippet

Sponsor: Mofya Diallo | Conditions: Anesthesia | Phase 4 | Status: WITHDRAWN